HAIs Are the Silent Endemic: Why the Numbers Don’t Add Up

For nearly 2 decades, the health care industry has cited the same sobering statistic: 1.7 million health care-associated infections (HAIs) and 99,000 deaths annually in the US. This translates to roughly 1 death every 5 minutes, 24/7, 365 days every year. Despite this staggering toll, these infections rarely make headlines, trigger emergency declarations, or appear prominently in national public health debates.

These figures are based on the 2007 analysis by R. Monina Klevens, DDS, and colleagues at the CDC, which relied largely on surveillance data from the late 1990s and early 2000s. Yet by any epidemiological definition, HAIs have quietly crossed a critical threshold: They are no longer episodic outbreaks or epidemics. They have become endemic.

But here is the sobering question: Do those numbers still reflect the reality based on present-day preventable hospital-associated infections (pHAIs)?

The epidemiological landscape has shifted dramatically. If anything, the burden of pHAIs is probably significantly underestimated. Surveillance is not lacking; the risk environment has fundamentally changed.

A Different Microbial Era

When Kleven’s analysis was published, the pathogens of concern in acute care hospitals were materially different. Since then, health care facilities have faced challenges such as:

• Escalation of hypervirulent Clostridioides difficile
• Emergence of Candida auris (now Candidozyma auris), a multidrug-resistant yeast that persists in the environment
• Increased prevalence of Stenotrophomonas maltophilia, including resistant strains
• Increased prevalence of multidrug-resistant Acinetobacter baumannii from the Middle East
• Persistent threats from Methicillin-resistant Staphylococcus aureus (MRSA)
• Emergence of carbapenem-resistant Enterobacteriaceae
• Increased prevalence of pan-resistant Klebsiella pneumoniae
• Multidrug-resistant Mycobacterium tuberculosis

Many of these organisms exhibit characteristics that were not fully appreciated or understood in earlier surveillance reports, including:

• Enhanced environmental persistence

• Biofilm formation
• Resistance to commonly used disinfectants
• Air and water system colonization
• Sublethal tolerance to disinfectant residues
• Multiantibiotic-resistant species

In short, the microbial burden and pathogenicity in health care environments have not remained static; they have evolved considerably.

The Overlooked Reservoirs: Sinks, Drains, Toilets, and Floors

Mounting evidence implicates environmental reservoirs in hospitals as active sources of pathogen transmission. Sink drains, P-traps, faucet aerators, and toilet plumbing systems can harbor biofilms containing viruses, fungi, and multidrug-resistant bacteria. Biofilm is not simply surface contamination; it is a structured suit of armor (extracellular polymeric matrix) that:

• Protects embedded organisms from disinfectants
• Facilitates antibiotic-resistant gene transfer (quorum sensing)
• Allows biofilm seeding into the surrounding patient care environments

Splash and aerosolization from contaminated drains can disseminate organisms to adjacent surfaces, medical equipment, and patient care zones. Likewise, toilet plume aerosolization can disperse microbes beyond the bowl, especially in high-use, shared facilities.

Floors have long been recognized as reservoirs of pathogens; however, the prevailing attitude, “what is on the floor stays on the floor,” has been shown to be clearly incorrect. Studies published within the last 10 years have shown that pathogens on the floor rapidly cross-contaminate above-floor surfaces throughout the patient care zone, where incidental hand contact can easily result in cross-contamination.

These reservoirs challenge a long-standing assumption: that environmental contamination is transient and superficial. In reality, many hospital surfaces are continuously being reseeded and contaminated. Researchers have determined that “If you’re not disinfecting for biofilm, you’re not disinfecting!”

The Hand Hygiene Paradox

Infection prevention programs have understandably emphasized hand hygiene. It is measurable, auditable, and intuitively linked to patient health and safety. Campaigns inspired by global initiatives from the World Health Organization, the Association for Professionals in Infection Prevention and Epidemiology, and the CDC have elevated adherence awareness. However, hand hygiene has become, in many institutions, the dominant intervention, all too often to the exclusion of environmental surface hygiene.

Here’s the paradox:

1. A clinician washes/sanitizes his or her hands
2. Then touches, for example, a contaminated bed rail, privacy curtain, stethoscope, call button, IV pump keypad, or overbed table
3. pHAI pathogen transfer occurs within seconds

Without rigorous proactive environmental surface hygiene and pathogen reservoir control, hand hygiene alone becomes a revolving door, an expensive, incomplete, and ineffective mitigation strategy. Hand hygiene is necessary; however, on its own, it is akin to the old Einstein anecdote: Doing the same thing over and over again and expecting a different result is the definition of insanity.

Why the Numbers Don’t Add Up

Several systematic factors suggest that legacy pHAI’s underestimate preventable harm:

Underdetection: Not all infections are captured in surveillance. Many postdischarge infections go unreported.

Shifting risk populations:

• Higher-risk patients
• More invasive devices
• Immunocompromised oncology and transplant patients, and an aging population

Antibiotic resistance: Resistant organisms prolong the length of stay, increase environmental shedding, and complicate eradication

Environmental persistence: Modern pathogens survive longer on dry surfaces and in plumbing systems than previously understood

Biofilm tolerance: Standard surface disinfection is rarely validated against mature biofilm reservoirs. Taken together, it is difficult to argue that a dataset (estimate) compiled from the 1990s HAIs fully reflects the microbial challenges hospitals face in 2026.

The Economics of environmental neglect: Hospital risk managers focus on:

• Centers for Medicare & Medicaid Services penalties
• Value-based purchasing
• Readmission metrics
• Litigation exposure

Yet environmental hygiene investments are typically treated as an operational cost center rather than a risk-reduction strategy. If a pHAI costs tens of thousands of dollars per case, and significantly more for resistant organisms, then insufficient environmental hygiene and control are clinical issues, and they are balance-sheet issues.

A multimodal systems-based approach: Reducing pHAIs requires moving beyond an emphasis on a single intervention. An effective proactive strategy must include:

• All departments enterprise wide must be involved
• Rigorous environmental surface hygiene and validation
• Biofilm-targeted interventions in plumbing systems
• Engineering controls to reduce splash and aerosolization
• Frequent disinfection and monitoring of high-touch surfaces
• Integrated hand + environmental surface + water management processes
• Ensuring that the products, tools, and disinfectants used address biofilm and spore-forming bacteria and fungi
• Daily disinfection processes must be proactive, not reactive
• Environmental service professionals must be educated and trained to perform their vital tasks and rewarded accordingly
• Validation is vital to ensure all the required surfaces are disinfected

Hand hygiene remains a key component of any infection prevention program; however, hand hygiene alone, without including environmental hygiene, is a waste of time, money, and effort.

The health care industry continues to cite 1.7 million infections and 99,000 deaths per year as a historical benchmark. The latest from the CDC is getting better: “On any given day, about 1 in 31 hospital patients has at least one health care-associated infection. Patients in the 2015 HAI Hospital Prevalence survey were at least 16% less likely than patients in the 2011 survey to have an HAI.” However, the number and virulence of microbial challenges have evolved, resistance has expanded, and environmental reservoirs are better understood.

If the pathogens, the reservoirs, and the risks have changed, then relying on legacy numbers and a single-point intervention does not align with present-day reality.

The numbers don’t add up! It is time to reassess not only how many infections are preventable, the impact on the bottom line, but also how prevention itself is defined and implemented.